Boc-D-Phe-ONp

Boc-D-Phe-ONp is a D-configured phenylalanine derivative bearing a Boc-protecting group on the amino functionality and an ONp ester (p-nitrophenyl ester) on the carboxylate, combining orthogonally useful protection with an activated carboxyl group. This reagent form is widely used in peptide chemistry and peptide intermediate workflows where controlled coupling is required, and the ONp leaving group supports efficient downstream formation of amide bonds under standard peptide synthesis conditions. The D stereochemistry makes it particularly relevant for preparing D-amino acid-containing peptides, stereochemical controls, and structure-activity or stability studies.

1. D-Amino Acid Peptide Building Block

Boc-D-Phe-ONp is used as a protected D-phenylalanine coupling reagent for assembling peptides that contain a stereochemically defined D-residue. Researchers performing custom peptide synthesis and peptide library construction rely on the Boc protection to maintain the amino group during segment coupling, while the ONp ester activation enables amide bond formation with appropriate nucleophiles during peptide assembly. This format is especially practical when D-amino acid incorporation is needed for probing conformational effects, protease resistance trends, or stereochemical specificity in peptide design.

2. Solution-Phase Coupling Intermediates

Boc-D-Phe-ONp is frequently selected as a peptide intermediate for solution-phase synthesis workflows that require an activated carboxyl component rather than a free amino acid. Medicinal chemistry groups developing peptidomimetics and stereochemically constrained analogs use this reagent to streamline the coupling step toward amide-linked fragments, supporting efficient formation of peptide bonds while keeping the amino functionality protected. The ONp ester activation is particularly useful in fragment condensation strategies where the activated acid functionality improves reactivity toward amine partners and helps maintain consistent coupling performance across multiple analogs.

3. Peptidomimetic SAR Fragment Synthesis

Boc-D-Phe-ONp supports the synthesis of D-Phe-containing fragments used in structure-activity relationship (SAR) studies for peptidomimetic and constrained peptide analog development. Chemical biology and medicinal chemistry teams often require rapid access to stereochemically defined building blocks to compare analog series, and the Boc/ONp combination provides a convenient protected activated form for generating amide-linked intermediates. By enabling controlled incorporation of the D-phenylalanine residue into larger scaffolds, this reagent helps researchers build and diversify peptide-like structures for downstream characterization and property screening workflows.

4. Pharmaceutical Intermediate Development

Boc-D-Phe-ONp is also applied in the preparation of specialized peptide-related pharmaceutical intermediates where a protected, activated amino acid derivative is needed for stepwise assembly of amide-containing structures. Process development and custom synthesis teams use this type of activated Boc-protected D-amino acid to construct defined intermediates that later feed into larger molecule assembly, including late-stage coupling sequences. The reagent's protected amino group and activated ONp ester functionality make it a practical choice for manufacturing-oriented intermediate synthesis that prioritizes reliable conversion to the next coupling stage.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines